1. Home
  2. PRCH vs RZLT Comparison

PRCH vs RZLT Comparison

Compare PRCH & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$16.73

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.40

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
RZLT
Founded
2012
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
420.8M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
PRCH
RZLT
Price
$16.73
$4.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$18.63
$9.67
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
26.32
EPS
0.01
N/A
Revenue
$482,414,000.00
N/A
Revenue This Year
$4.15
N/A
Revenue Next Year
$17.05
N/A
P/E Ratio
$1,794.00
N/A
Revenue Growth
10.18
N/A
52 Week Low
$6.36
$1.07
52 Week High
$19.44
$11.46

Technical Indicators

Market Signals
Indicator
PRCH
RZLT
Relative Strength Index (RSI) 51.31 41.81
Support Level $9.15 $2.91
Resistance Level $17.03 $4.71
Average True Range (ATR) 0.70 0.27
MACD -0.12 -0.04
Stochastic Oscillator 12.96 3.73

Price Performance

Historical Comparison
PRCH
RZLT

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: